The developmental origins of disease: implications for primary prevention of diseases in children (and the rest of us)
Keywords:
developmental origins of disease, postmarket laws, premarket laws, mechanistic data,Abstract
Recent research into the developmental origins of disease, revealing risks to children, shows why the vast majority of laws in the U.S. and probably those of many other countries poorly protect children from toxic substances, and what we might learn from this for other circumstances. Once we recognize numerous limitations of current laws, it becomes incumbent upon decision makers to find and adopt strategies to better protect children. In the first instance, laws that permit exposures of chemical substances to children and adults without any knowledge of their toxicity should be modified a) to require toxicity testing of new products and b) to increase the toxicity testing of products (and pollutants) already in commerce. Because instituting the political change that would likely be necessary, in the short to intermediate term scientists should seek to use existing scientific tools to more quickly identify toxic products and to develop new types of studies with the goal of better preventing harm to the public. Scientific research may to some extent compensate for legal inaction.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.